甲状腺乳头状癌概述
Journal: Basic Medical Theory Research DOI: 10.12238/bmtr.v4i4.5459
Abstract
甲状腺乳头状癌(papillary thyroid cancer,PTC)是所有甲状腺癌中最常见的恶性肿瘤,也是发病率迅速上升的少数癌症之一。PTC在生物学上通常是惰性的,大多预后良好,但超过25%的PTC患者在长期随访中出现复发。本文提供了PTC最新的简要概述,主要集中在流行病学、危险因素、诊断、治疗及预后等。
Keywords
甲状腺乳头状癌；流行病学；危险因素；诊断；治疗；预后
Full Text
PDF - Viewed/Downloaded: 0 TimesReferences
[1] Yu J, Mai W, Cui Y, Kong L. Key genes and pathways predicted in papillary thyroid carcinoma based on bioinforma tics analysis. J Endocrinol Invest. 2016 Nov;39(11):1285-1293.
[2] Niederer-Wüst SM, Jochum W, Förbs D,Brändle M, Bilz S, Clerici T, Oettli R, Müller J, Haile SR, Ess S, Stoeckli SJ, Broglie MA. Impact of clinical risk scores and BRAF V600E mutation status on outcome in papillary thyroid cancer.Surgery.2015 Jan;157(1):119-25.
[3] Sciuto R, Romano L, Rea S, Marandino F, Sperduti I,Maini CL.Natural history and clinical outcome of differentiat ed thyroid carcinoma: a retrospective analysis of 1503 pati ents treated at a single institution. Ann Oncol.2009 Oct;20 (10):1728-35.
[4] Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM. Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013. JAMA. 2017 Apr 4;317(13):1338-1348.
[5] Morton LM, Karyadi DM, Stewart C, Bogdanova TI, Dawson ET, Steinberg MK, Dai J, Hartley SW, Schonfeld SJ, Sampson JN, Maruvka YE, Kapoor V, Ramsden DA, Carvajal-Garcia J, Perou CM, Parker JS, Krznaric M, Yeager M, Boland JF, Hutchinson A, Hicks BD, Dagnall CL, Gastier-Foster JM, Bowen J, Lee O, Machiela MJ,Cahoon EK, Brenner AV, Mabuchi K, Drozdovitch V, Masiuk S, Chepurny M, Zurnadzhy LY, Hatch M, Berrington de Gonzalez A, Thomas GA, Tronko MD, Getz G, Chanock SJ. Radiation-related genomic profile of papillary thyroid carcinoma after the Chernobyl accident. Science. 2021 May 14;372(6543):eabg2538.
[6] Veiga LH, Holmberg E, Anderson H, Pottern L, Sadetzki S, Adams MJ, Sakata R, Schneider AB, Inskip P, Bhatti P, Johansson R, Neta G, Shore R, de Vathaire F, Damber L, Kleinerman R, Hawkins MM, Tucker M, Lundell M, Lubin JH. Thyroid Cancer after Childhood Exposure to External Radia tion: An Updated Pooled Analysis of 12 Studies. Radiat Res. 2016May;185(5):473-84.
[7] 嘉勉.甲状腺乳头状癌的近亲发病风险高[J]. 中华医学信息导报,2013,(22):8.
[8] Lee J-H, Hwang Y, Song R-Y, et al.Relationship between iodine levels and papillary thyroid carci-noma: A systematic review and meta-analysis. Head & Neck.2017;39:1711-1718.
[9] Hu MJ, Zhang C, Liang L, Wang SY, Zheng XC, Zhang Q,Jiang CX, Zhong Q, Huang F. Fasting serum glucose, thyroidstimulating hormone, and thyroid hormones and risk of papillary thyroid cancer: A case-control study. Head Neck. 2019 Jul;41(7):2277-2284.
[10] Pazaitou-Panayiotou K, Michalakis K, Paschke R. Thyro id cancer in patients with hyperthyroidism. Horm Metab Res. 2012 Apr;44(4):255-62.
[11] 贾明扬,贺建业,陈东,等.甲状腺乳头状癌的危险因素分析[J].中国医药,2021,(03):404-407.
[12] Aschebrook-Kilfoy B, Sabra MM, Brenner A, Moore SC, Ron E, Schatzkin A, Hollenbeck A, Ward MH. Diabetes and thyroidcancer risk in the National Institutes of Health-AARP Diet and Health Study. Thyroid. 2011 Sep;21(9):957-63.
[13] 肖小琴,冷敏芳,陆艳萍,等.甲状腺乳头状癌组织学亚型及其分子研究进展[J].癌症进展,2021,(15):1517-1519+1529.
[14] Qi W, Shi C, Zhang P, Feng L, Wang J, Chen D. Effect of BRAF V600E mutation detection of fine-needle aspirationbiopsy on diagnosis and treatment guidance of papillary thyroid carcinoma. Pathol Res Pract. 2020 Aug;216(8):153037.
[15] Ferrari SM, Fallahi P, Ruffilli I, Elia G, Ragusa F, Paparo SR, Ulisse S, Baldini E, Giannini R, Miccoli P, Antonelli A, Basolo F. Molecular testing in the diagnosis of differen tiated thyroid carcinomas. Gland Surg. 2018 Aug;7(Suppl 1):S19-S29.
[16] Chang YW, Lee HY, Ji WB, Kim HY, Kim WY, Lee JB, Son GS. Detailed comparison of robotic and endoscopic transaxill ary thyroidectomy. Asian J Surg. 2020 Jan;43(1):234-239.
[17] Rao S, Wang Z, Pan C, Wang Y, Lin Z, Pan Z, Yu J. Preli minary Study on the Clinical Significance and Methods of Using Carbon Nanoparticles in Endoscopic Papillary Thyroid Cancer Surgery. Contrast Media Mol Imaging.2021 Apr 26;2021:6652315.
[18] 贾浩,韦伟.甲状腺乳头状癌术后复发靶向治疗进展[J].中国实用外科杂志,2021,(08):934-939.
[19] Ito Y, Miyauchi A, Kobayashi K, Miya A. Prognosis and growth activity depend on patient age in clinical and subcli nical papillary thyroid carcinoma. Endocr J.2014;61(3):205- 13.
[2] Niederer-Wüst SM, Jochum W, Förbs D,Brändle M, Bilz S, Clerici T, Oettli R, Müller J, Haile SR, Ess S, Stoeckli SJ, Broglie MA. Impact of clinical risk scores and BRAF V600E mutation status on outcome in papillary thyroid cancer.Surgery.2015 Jan;157(1):119-25.
[3] Sciuto R, Romano L, Rea S, Marandino F, Sperduti I,Maini CL.Natural history and clinical outcome of differentiat ed thyroid carcinoma: a retrospective analysis of 1503 pati ents treated at a single institution. Ann Oncol.2009 Oct;20 (10):1728-35.
[4] Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM. Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013. JAMA. 2017 Apr 4;317(13):1338-1348.
[5] Morton LM, Karyadi DM, Stewart C, Bogdanova TI, Dawson ET, Steinberg MK, Dai J, Hartley SW, Schonfeld SJ, Sampson JN, Maruvka YE, Kapoor V, Ramsden DA, Carvajal-Garcia J, Perou CM, Parker JS, Krznaric M, Yeager M, Boland JF, Hutchinson A, Hicks BD, Dagnall CL, Gastier-Foster JM, Bowen J, Lee O, Machiela MJ,Cahoon EK, Brenner AV, Mabuchi K, Drozdovitch V, Masiuk S, Chepurny M, Zurnadzhy LY, Hatch M, Berrington de Gonzalez A, Thomas GA, Tronko MD, Getz G, Chanock SJ. Radiation-related genomic profile of papillary thyroid carcinoma after the Chernobyl accident. Science. 2021 May 14;372(6543):eabg2538.
[6] Veiga LH, Holmberg E, Anderson H, Pottern L, Sadetzki S, Adams MJ, Sakata R, Schneider AB, Inskip P, Bhatti P, Johansson R, Neta G, Shore R, de Vathaire F, Damber L, Kleinerman R, Hawkins MM, Tucker M, Lundell M, Lubin JH. Thyroid Cancer after Childhood Exposure to External Radia tion: An Updated Pooled Analysis of 12 Studies. Radiat Res. 2016May;185(5):473-84.
[7] 嘉勉.甲状腺乳头状癌的近亲发病风险高[J]. 中华医学信息导报,2013,(22):8.
[8] Lee J-H, Hwang Y, Song R-Y, et al.Relationship between iodine levels and papillary thyroid carci-noma: A systematic review and meta-analysis. Head & Neck.2017;39:1711-1718.
[9] Hu MJ, Zhang C, Liang L, Wang SY, Zheng XC, Zhang Q,Jiang CX, Zhong Q, Huang F. Fasting serum glucose, thyroidstimulating hormone, and thyroid hormones and risk of papillary thyroid cancer: A case-control study. Head Neck. 2019 Jul;41(7):2277-2284.
[10] Pazaitou-Panayiotou K, Michalakis K, Paschke R. Thyro id cancer in patients with hyperthyroidism. Horm Metab Res. 2012 Apr;44(4):255-62.
[11] 贾明扬,贺建业,陈东,等.甲状腺乳头状癌的危险因素分析[J].中国医药,2021,(03):404-407.
[12] Aschebrook-Kilfoy B, Sabra MM, Brenner A, Moore SC, Ron E, Schatzkin A, Hollenbeck A, Ward MH. Diabetes and thyroidcancer risk in the National Institutes of Health-AARP Diet and Health Study. Thyroid. 2011 Sep;21(9):957-63.
[13] 肖小琴,冷敏芳,陆艳萍,等.甲状腺乳头状癌组织学亚型及其分子研究进展[J].癌症进展,2021,(15):1517-1519+1529.
[14] Qi W, Shi C, Zhang P, Feng L, Wang J, Chen D. Effect of BRAF V600E mutation detection of fine-needle aspirationbiopsy on diagnosis and treatment guidance of papillary thyroid carcinoma. Pathol Res Pract. 2020 Aug;216(8):153037.
[15] Ferrari SM, Fallahi P, Ruffilli I, Elia G, Ragusa F, Paparo SR, Ulisse S, Baldini E, Giannini R, Miccoli P, Antonelli A, Basolo F. Molecular testing in the diagnosis of differen tiated thyroid carcinomas. Gland Surg. 2018 Aug;7(Suppl 1):S19-S29.
[16] Chang YW, Lee HY, Ji WB, Kim HY, Kim WY, Lee JB, Son GS. Detailed comparison of robotic and endoscopic transaxill ary thyroidectomy. Asian J Surg. 2020 Jan;43(1):234-239.
[17] Rao S, Wang Z, Pan C, Wang Y, Lin Z, Pan Z, Yu J. Preli minary Study on the Clinical Significance and Methods of Using Carbon Nanoparticles in Endoscopic Papillary Thyroid Cancer Surgery. Contrast Media Mol Imaging.2021 Apr 26;2021:6652315.
[18] 贾浩,韦伟.甲状腺乳头状癌术后复发靶向治疗进展[J].中国实用外科杂志,2021,(08):934-939.
[19] Ito Y, Miyauchi A, Kobayashi K, Miya A. Prognosis and growth activity depend on patient age in clinical and subcli nical papillary thyroid carcinoma. Endocr J.2014;61(3):205- 13.
Copyright © 2022 窦建英, 刘阁玲
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License